<DOC>
	<DOCNO>NCT00564850</DOCNO>
	<brief_summary>The purpose study assess efficacy triptorelin 11.25 mg pamoate delay premature onset puberty girl le 9 year boys less 10 year . This measure assess proportion child suppress Luteinizing Hormone ( LH ) response Gonadotropin Releasing Hormone ( GnRH ) test perform 3 month injection triptorelin 11.25 mg .</brief_summary>
	<brief_title>Efficacy Safety Study Pamoate Triptorelin Children With Precocious Puberty</brief_title>
	<detailed_description />
	<mesh_term>Puberty , Precocious</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<criteria>Inclusion Criteria screen phase : Onset sex characteristic ( Tanner method ) breast development girl testicular enlargement boys age 8 year girls 9 year boys . Weight ≥ 20 kg . Inclusion Criteria treatment phase : Proven central precocious puberty define onset sex characteristic development ( accord Tanner method ) diagnose age 8 year girls 9 year boys . Age evaluation le 9 year girls 10 year boys . A pubertal response LH GnRH test sex ( stimulate LH ≥ 5 IU/l ) . Difference Bone age ( BA ) ( accord Greulich et Pyle method ) Chronological age ( CA ) &gt; 1 year . Testosterone level ≥ 0.5 ng/ml boy . Patient peripheral precocious puberty : extrapituitary secretion gonadotropin gonadotropinindependent gonadal adrenal sex steroid secretion . Patient cerebral tumour require neurosurgery cerebral irradiation . Patient Body Weight ≥ 125 % ideal weight height age ( growth curve ) . The patient receive previous treatment GnRH analogue , medroxyprogesterone cyproterone acetate .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>